NCT06652984Completed
Effectiveness of Mobile Respiratory Training in Ankylosing Spondylitis
Effectiveness of Respiratory Muscle Training Using a Mobile Respiratory Trainer in People With Ankylosing Spondylitis
Source: ClinicalTrials.gov · Last updated 8 Jul 2025
Brief summary (registry, in English)
Introduction and aim; Low functionality of respiratory muscles is frequently observed in various diseases such as chronic obstructive pulmonary disease, cystic fibrosis, idiopathic pulmonary fibrosis, and rheumatological diseases such as ankylosing spondylitis. Strengthening the respiratory muscles is a part of the treatment in such disease groups, and it has been reported that the quality of life of patients increases with the improvement in the respiratory muscles. Stavrou et al. In a study published in 2021, they achieved an increase in VO2max and maximum respiratory power in athletes after an exercise program with the AirOFit PRO™ (AirOFit, Copenhagen, Denmark) branded mobile breathing exercise device, which they introduced as a new technology. However, there is no study yet reporting the use of this device in rheumatological diseases. The aim of this study is to investigate the effects of personalized breathing exercises with the AirOFit PRO™ (AirOFit, Copenhagen, Denmark) branded mobile breathing exercise device on respiratory muscles and functional exercise capacity, as well as on specific outcomes of the disease, in patients with ankylosing spondylitis. Hypotheses of the study; a) Hypothesis H1: Personalised breathing exercises applied with a mobile respiratory exercise device in patients with ankylosing spondylitis have a positive effect on respiratory capacity and activities of daily living in patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 18 Oct 2024
- Start date
- 5 Nov 2024
- Primary completion date
- 12 May 2025
- Lead sponsor
- Uşak University
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT06652984
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 5 Nov 2024 to the primary completion date, 12 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- The presence of diseases that affect the function of the respiratory system (such as pneumonia, pleurisy, empyema, pneumothorax, hemothorax, hydrothorax, atelectasis, pulmonary oedema, pulmonary hypertension, emphysema, and lung cancer).
- Significant physical disability or impairment (regular use of walking aids, etc.)
Other
- The presence of a regular exercise habit (regularly 3 days a week for at least six months).
Who the study is looking for
- Volunteer for the study
- Be over 18 years old
- To be in the follow-up of Usak University Rheumatology outpatient clinic
- Stability in medical treatment (keeping disease activity under control with the same medical treatment for at least 6 months)
Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Usak University Coordinator of this site? Confirm its status | Uşak | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.